Who Is Ovitra Biotechnology?

Brad R. Lindsey, PhD
Owner, CEO


Brad received his BS in Ag Economics in 1982 and a MAgr in
Animal Science in 1984, both from Texas A&M University. He
then worked 8 years for Granada Corporation in the Equine
Services & Genetics Divisions, where his duties included  
collection, transfer, freezing, thawing, splitting & biopsy of
embryos, early pregnancy detection & fetal sexing with
ultrasound. In 1991, Brad helped Aloka design a trans-vaginal
ultrasound probe for bovine oocyte recovery, allowing
Granada to become the first company in the USA to
commercialize in vitro production of bovine embryos. In 1992,
Brad began commercial IVF services for Trans Ova Genetics.

In 1998, Lindsey completed his PhD under Dr. Jim Kinder at
the University of Nebraska-Lincoln. He subsequently held
positions with Stroud Veterinary Embryo Services, AB
Technology, Inc. (now Bioniche), Minitube of America, Genetic
Resources Int’l and OvaGenix, LP. In 2006, Brad started his
own consulting business, Rex Consulting, which is now Ovitra.

For Dr. Lindsey's complete Bio & CV,
click here.

American Embryo Transfer Association Certified
International Embryo Transfer Society Freeze Code: E1687
Personnel